Fever after peripheral blood stem cell infusion in haploidentical transplantation with post-transplant cyclophosphamide
Tài liệu tham khảo
Kanakry, 2016, Modern approaches to HLA-haploidentical blood or marrow transplantation, Nat Rev Clin Oncol, 13, 10, 10.1038/nrclinonc.2015.128
Solomon, 2015, Total body irradiation based myeloablative haploidentical stem cell transplantation is a safe and effective alternative to unrelated donor transplantation in patients without matched sibling donors, Biol Blood Marrow Transplant, 21, 1299, 10.1016/j.bbmt.2015.03.003
Bashey, 2013, T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation, J Clin Oncol, 31, 1310, 10.1200/JCO.2012.44.3523
Ruggeri, 2015, Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia, Leukemia, 29, 1891, 10.1038/leu.2015.98
O'Donnell, 2015, High fever occurring 4 to 5 days post-transplant of haploidentical bone marrow or peripheral blood stem cells after reduced-intensity conditioning associated with the use of post-transplant cyclophosphamide as prophylaxis for graft-versus-host disease, Biol Blood Marrow Transplant, 21, 197, 10.1016/j.bbmt.2014.10.008
Chen, 2015, Febrile reaction associated with the infusion of Haploidentical peripheral blood stem cells: incidence, clinical features, and risk factors, Transfusion, 55, 2023, 10.1111/trf.13167
Abboud, 2016, Severe cytokine release syndrome following T-cell replete peripheral blood haploidentical donor transplant is associated with poor survival and anti-IL6 therapy is safe and well tolerated, Biol Blood Marrow Transplant, 22, 1851, 10.1016/j.bbmt.2016.06.010
Tomblyn, 2009, Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective, Biol Blood Marrow Transplant, 15, 1143, 10.1016/j.bbmt.2009.06.019
Holtan, 2015, Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation, Blood, 125, 1333, 10.1182/blood-2014-10-609032
Sugita, 2015, HLA-haploidentical peripheral blood stem cell transplantation with post-transplant cyclophosphamide after busulfan-containing reduced-intensity conditioning, Biol Blood Marrow Transplant, 21, 1646, 10.1016/j.bbmt.2015.06.008